Anticancer maintenance chemotherapy prolonged prognosis of metastatic urothelial carcinoma patients: A single institute retrospective study using propensity score matching-Reference-Cited by-同舟云学术

Anticancer maintenance chemotherapy prolonged prognosis of metastatic urothelial carcinoma patients: A single institute retrospective study using propensity score matching

Published:2022-08-24 Issue:11 Volume:29 Page:1294-1303
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Yamamoto Akinaru¹,Kawashima Atsunari¹^ORCID,Uemura Toshihiro¹,Yamamichi Gaku¹,Tomiyama Eisuke¹^ORCID,Koh Yoko¹^ORCID,Matsushita Makoto¹,Kato Taigo¹^ORCID,Hatano Koji¹,Uemura Motohide¹,Imamura Ryoichi¹,Nonomura Norio¹

Affiliation:

1. Department of Urology Osaka University Graduate School of Medicine Osaka Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14987

Reference26 articles.

1. Cancer statistics, 2019

2. UPDATE ON CHEMOTHERAPY FOR ADVANCED BLADDER CANCER

3. Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers

4. Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

5. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching;Clinical Genitourinary Cancer;2024-12

2. Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution;International Journal of Clinical Oncology;2024-06-08